Furthermore, our genomic analysis identified frequent genetic alterations in RNASEK particularly deep deletions in miscellaneous neuroepithelial tumors, amplifications in SARC, and finally mutations in endometrial cancers. This evidence concerns the gene RNASEK and neuroepithelial neoplasm.